Biotech Values

[RockRat]

I'm not so sure that t-enox is immaterial to Teva from an investor's standpoint. Peter calculated that it would be a 15% bump in their profits (I incorrectly posted .15/share from memory recently; here's the correction):

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=55013723

This is why I, ilpapa, and maybe a few others have been wondering aloud how much trash Teva can talk and for how long before they get sued by shareholders if they fail to get approval.

Regards, RockRat